This lecture covers the use of immunotherapies to promote the cancer-immunity cycle, including the trafficking of T cells to tumors, priming and activation, infiltration of T cells, and tumor elimination. It also discusses antibody-based immunotherapy, checkpoint inhibitors, and genetically engineered T-cells for cancer treatment.